Down-regulation of p-Akt by anti-IGF-1R antibodies occurs in cells of many different lineages, including small cell lung cancer (SCLC) [29], acute myeloid leukemia [30], and non-small cell lung cancer [31]. Here, IGF1R is linked to acute myeloid leukemia.